A feasibility study in oesophageal carcinoma using deep loco-regional hyperthermia combined with concurrent chemotherapy followed by surgery
/in Esophageal Carcinoma, Hyperthermia, International Publications /von 2004-09-01 / Int J Hyperthermia 2004 Sep;20(6):647-59[Immunotherapy–perspectives in therapy of ovarian carcinomas]
/in International Publications, Ovarian Cancer /von 2004-09-01 / Ceska Gynekol 2004 Sep;69(5):372-5Dendritic cell-based immunotherapy in thyroid malignancies
/in Dendritic Cells, International Publications, Thyroid Cancer /von 2004-09-01 / Curr. Drug Targets Immune Endocr. Metabol. Disord. 2004 Sep;4(3):245-51
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution